Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain

Stefania Petrosino, Akbar Ahmad, Gabriele Marcolongo, Emanuela Esposito, Marco Allarà, Roberta Verde, Salvatore Cuzzocrea, Vincenzo Di Marzo

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Palmitoylethanolamide (PEA) is produced by mammalian cells from its biosynthetic precursor, N-palmitoyl-phosphatidyl-ethanolamine, and inactivated by enzymatic hydrolysis to palmitic acid and ethanolamine. Apart from fatty acid amide hydrolase (FAAH), the N-acylethanolamine-hydrolyzing acid amidase (NAAA), a lysosomal enzyme, was also shown to catalyze the hydrolysis of PEA and to limit its analgesic and anti-inflammatory action. Here we report the finding of a new potential inhibitor of NAAA, EPT4900 (4,5-diacetyloxy-9,10-dioxo-anthracene-2-carboxylic acid, diacerein). EPT4900 exhibited a high inhibitory activity on human recombinant NAAA over-expressed in HEK293 cells (HEK-NAAA cells). EPT4900 selectively increased the levels of PEA in intact HEK-NAAA cells, and inhibited inflammation as well as hyperalgesia in rats treated with an intraplantar injection of carrageenan. This latter effect was accompanied by elevation of PEA endogenous levels in the paw skin.

Original languageEnglish (US)
Pages (from-to)9-14
Number of pages6
JournalPharmacological Research
Volume91
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

diacetylrhein
amidase
Acute Pain
Analgesics
Ethanolamine
Acids
Hydrolysis
Palmitic Acid
HEK293 Cells
Carrageenan
Hyperalgesia
Non-Steroidal Anti-Inflammatory Agents
Carboxylic Acids
Inflammation
Skin
Injections
palmidrol
N-acylethanolamines
Enzymes

Keywords

  • Diacerein
  • Inflammation
  • NAAA
  • Palmitoylethanolamide

ASJC Scopus subject areas

  • Pharmacology
  • Medicine(all)

Cite this

Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain. / Petrosino, Stefania; Ahmad, Akbar; Marcolongo, Gabriele; Esposito, Emanuela; Allarà, Marco; Verde, Roberta; Cuzzocrea, Salvatore; Di Marzo, Vincenzo.

In: Pharmacological Research, Vol. 91, 2015, p. 9-14.

Research output: Contribution to journalArticle

Petrosino, Stefania ; Ahmad, Akbar ; Marcolongo, Gabriele ; Esposito, Emanuela ; Allarà, Marco ; Verde, Roberta ; Cuzzocrea, Salvatore ; Di Marzo, Vincenzo. / Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain. In: Pharmacological Research. 2015 ; Vol. 91. pp. 9-14.
@article{f48ee9b8bdf74490a4086b21849a6bcb,
title = "Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain",
abstract = "Palmitoylethanolamide (PEA) is produced by mammalian cells from its biosynthetic precursor, N-palmitoyl-phosphatidyl-ethanolamine, and inactivated by enzymatic hydrolysis to palmitic acid and ethanolamine. Apart from fatty acid amide hydrolase (FAAH), the N-acylethanolamine-hydrolyzing acid amidase (NAAA), a lysosomal enzyme, was also shown to catalyze the hydrolysis of PEA and to limit its analgesic and anti-inflammatory action. Here we report the finding of a new potential inhibitor of NAAA, EPT4900 (4,5-diacetyloxy-9,10-dioxo-anthracene-2-carboxylic acid, diacerein). EPT4900 exhibited a high inhibitory activity on human recombinant NAAA over-expressed in HEK293 cells (HEK-NAAA cells). EPT4900 selectively increased the levels of PEA in intact HEK-NAAA cells, and inhibited inflammation as well as hyperalgesia in rats treated with an intraplantar injection of carrageenan. This latter effect was accompanied by elevation of PEA endogenous levels in the paw skin.",
keywords = "Diacerein, Inflammation, NAAA, Palmitoylethanolamide",
author = "Stefania Petrosino and Akbar Ahmad and Gabriele Marcolongo and Emanuela Esposito and Marco Allar{\`a} and Roberta Verde and Salvatore Cuzzocrea and {Di Marzo}, Vincenzo",
year = "2015",
doi = "10.1016/j.phrs.2014.10.008",
language = "English (US)",
volume = "91",
pages = "9--14",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain

AU - Petrosino, Stefania

AU - Ahmad, Akbar

AU - Marcolongo, Gabriele

AU - Esposito, Emanuela

AU - Allarà, Marco

AU - Verde, Roberta

AU - Cuzzocrea, Salvatore

AU - Di Marzo, Vincenzo

PY - 2015

Y1 - 2015

N2 - Palmitoylethanolamide (PEA) is produced by mammalian cells from its biosynthetic precursor, N-palmitoyl-phosphatidyl-ethanolamine, and inactivated by enzymatic hydrolysis to palmitic acid and ethanolamine. Apart from fatty acid amide hydrolase (FAAH), the N-acylethanolamine-hydrolyzing acid amidase (NAAA), a lysosomal enzyme, was also shown to catalyze the hydrolysis of PEA and to limit its analgesic and anti-inflammatory action. Here we report the finding of a new potential inhibitor of NAAA, EPT4900 (4,5-diacetyloxy-9,10-dioxo-anthracene-2-carboxylic acid, diacerein). EPT4900 exhibited a high inhibitory activity on human recombinant NAAA over-expressed in HEK293 cells (HEK-NAAA cells). EPT4900 selectively increased the levels of PEA in intact HEK-NAAA cells, and inhibited inflammation as well as hyperalgesia in rats treated with an intraplantar injection of carrageenan. This latter effect was accompanied by elevation of PEA endogenous levels in the paw skin.

AB - Palmitoylethanolamide (PEA) is produced by mammalian cells from its biosynthetic precursor, N-palmitoyl-phosphatidyl-ethanolamine, and inactivated by enzymatic hydrolysis to palmitic acid and ethanolamine. Apart from fatty acid amide hydrolase (FAAH), the N-acylethanolamine-hydrolyzing acid amidase (NAAA), a lysosomal enzyme, was also shown to catalyze the hydrolysis of PEA and to limit its analgesic and anti-inflammatory action. Here we report the finding of a new potential inhibitor of NAAA, EPT4900 (4,5-diacetyloxy-9,10-dioxo-anthracene-2-carboxylic acid, diacerein). EPT4900 exhibited a high inhibitory activity on human recombinant NAAA over-expressed in HEK293 cells (HEK-NAAA cells). EPT4900 selectively increased the levels of PEA in intact HEK-NAAA cells, and inhibited inflammation as well as hyperalgesia in rats treated with an intraplantar injection of carrageenan. This latter effect was accompanied by elevation of PEA endogenous levels in the paw skin.

KW - Diacerein

KW - Inflammation

KW - NAAA

KW - Palmitoylethanolamide

UR - http://www.scopus.com/inward/record.url?scp=84910619396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910619396&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2014.10.008

DO - 10.1016/j.phrs.2014.10.008

M3 - Article

VL - 91

SP - 9

EP - 14

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -